Rating Change
Stifel reiterated its Buy rating on ClearPoint Neuro, Inc. (NASDAQ:CLPT) on October 29, 2026.
reiterateNASDAQ:CLPT
Stifel Reiterates Buy Rating on ClearPoint Neuro, Inc. (CLPT)
Stifel reiterated its Buy rating on ClearPoint Neuro, Inc. (NASDAQ:CLPT) on October 29, 2026.
At publication ·
What changed
ClearPoint Neuro, Inc. (NASDAQ:CLPT) · reiterate
- Firm
- Stifel
- Rating
- Buy to Buy
- Price at event
- $10.69
- Market capitalization
- $368.9M
At a glance
Key takeaways
- Stifel reiterated a Buy rating on ClearPoint Neuro (CLPT) on October 29, 2026, with the stock trading at $10.69 and a market cap of $368.9 million.
Market Context
ClearPoint Neuro, Inc. operates in the Healthcare sector. The stock currently trades at $10.69 with a market capitalization of $368.9M. The stock has declined 58.5% over the past 52 weeks.
Analyst coverage from Stifel provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for ClearPoint Neuro, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for ClearPoint Neuro, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 29, 2026 | Stifel | Buy | N/A |
| Jun 18, 2026 | B. Riley Securities | Buy | N/A |
| Mar 18, 2026 | B. Riley Securities | Buy | N/A |
| Mar 05, 2026 | B. Riley Securities | Buy | N/A |
| Aug 01, 2025 | Stifel | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View CLPT Stock Page
Frequently Asked Questions
What does the Buy rating mean for CLPT?
A rating of Buy from Stifel reflects the analyst's outlook on ClearPoint Neuro, Inc. (NASDAQ:CLPT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CLPT forecast page.